世界のバイオマーカー市場...市場調査レポートについてご紹介

【英文タイトル】Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013-2018)

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

TABLE OF CONTENTS

1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 STAKEHOLDERS
1.4 RESEARCH METHODOLOGY
1.4.1 MARKET SIZE
1.4.2 KEY DATA POINTS FROM SECONDARY SOURCES
1.4.3 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 DEFINITION OF BIOMARKERS
3.2 BIOMARKERS & ITS TYPES
3.3 BIOMARKERS MARKET
3.3.1 MARKET SEGMENTATION
3.3.2 CHALLENGES & OPPORTUNITIES
3.3.2.1 Challenges
3.3.2.1.1 Variability
3.3.2.1.2 Ethical considerations & acceptability
3.3.2.2 Opportunities
3.3.2.2.1 Personalized medicine
3.3.2.2.2 Companion diagnostics
3.3.3 DRIVERS & RESTRAINTS
3.3.3.1 Drivers
3.3.3.1.1 High demand boosts the growth of the biomarkers market globally
3.3.3.1.2 Strategic collaborations lead to increasing applications in the market
3.3.3.1.3 Technological advances contribute to growth
3.3.3.1.4 The rising prevalence of the disease forms
3.3.3.1.5 FDA support for biomarkers development
3.3.3.2 Restraints
3.3.3.2.1 Low capital investment & cost-benefit hinders growth of biomarkers
3.3.3.2.2 Biomarkers not a profitable market for small organizations
3.3.3.2.3 Sample collection & storage
3.3.3.2.4 Limited biomarkers validation
3.3.3.2.5 Need for new R&D models with greater precision & flexibility

4 GLOBAL BIOMARKERS MARKET, BY DISCOVERY TECHNOLOGIES
4.1 INTRODUCTION
4.2 IMAGING TECHNOLOGIES FOR BIOMARKERS DISCOVERY
4.2.1 POSITRON EMISSION TOMOGRAPHY (PET)
4.2.2 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY(SPECT)
4.2.3 ULTRASOUND
4.2.4 MAGNETIC RESONANCE IMAGING (MRI)
4.2.5 COMPUTED TOMOGRAPHY (CT)
4.3 OMICS TECHNOLOGIES FOR BIOMARKERS DISCOVERY
4.3.1 PROTEOMICS
4.3.1.1 Mass spectrometry
4.3.1.1.1 MALDI mass spectrometry
4.3.1.1.2 Imaging mass spectrometry
4.3.1.2 2D Gel Electrophoresis
4.3.1.3 Protein microarray technology
4.3.1.4 Antibody array technology
4.3.1.5 Peptide array technology
4.3.2 GENOMICS
4.3.2.1 Whole genome sequencing
4.3.2.2 Genotyping
4.3.2.3 Epigenetics
4.3.3 TRANSCRIPTOMICS
4.3.3.1 Microarrays
4.3.3.2 Gene expression profiling
4.3.4 METABOLOMICS
4.3.4.1 Capillary electrophoresis
4.3.4.2 Mass spectrometry based kits
4.3.4.3 Nuclear Magnetic Resonance(NMR)
4.4 BIOINFORMATICS
4.4.1 CLUSTER ANALYSIS
4.4.2 STATISTICAL ANALYSIS
4.4.3 CELL SIGNAL PATHWAYS
4.4.4 COMPUTER AIDED DESIGN
4.4.5 DATA MINING
4.4.6 PROTEIN INTERACTION MAPS

5 SERVICES MARKET OF BIOMARKERS
5.1 INTRODUCTION
5.2 CLINICAL
5.2.1 SAMPLE PREPARATION
5.2.2 ASSAY DEVELOPMENT
5.2.3 BIOMARKERS VALIDATION & TESTING
5.2.3.1 Feasibility Studies and choice of assay & biomarkers
5.2.3.2 Long lead time required for Biomarkers Assay preparation
5.3 BIOINFORMATICS
5.3.1 FUNCTIONAL GENOMICS & PROTEOMICS DRIVE THE DEMAND FOR BIOINFORMATICS

6 BIOMARKERS APPLICATION MARKET
6.1 INTRODUCTION
6.2 DRUG DISCOVERY & DEVELOPMENT
6.2.1 CLINICAL TRIALS
6.2.1.1 Preclinical Development
6.2.1.2 Phase I drug development
6.2.1.3 Phase II drug development
6.2.1.4 Phase III drug development
6.2.1.5 Phase IV drug development
6.3 PERSONALIZED MEDICINE
6.4 MOLECULAR DIAGNOSTICS
6.4.1 MOLECULAR DIAGNOSTICS IS A DYNAMIC & RAPIDLY BROADENING MARKET
6.4.2 TRENDS IN THE DIAGNOSTICS MARKET
6.4.3 CHALLENGES
6.4.3.1 Nucleic acids pose a challenge to the molecular diagnostics field
6.4.3.2 Molecular diagnostics market lacks a collaborated effort
6.4.4 DRIVER
6.4.4.1 Increase in the incidence of diseases spurs the growth of the diagnostics market
6.4.5 RESTRAINT
6.4.5.1 The “interest-information” restricts growth of molecular diagnostics
6.4.6 MOLECULAR DIAGNOSTICS IN MAJOR INDICATIONS
6.4.6.1 Oncology
6.4.6.2 Cardiology
6.4.6.3 Neurology
6.4.6.4 Other treatment areas
6.4.7 BIOMARKERS IN DIAGNOSTICS
6.4.8 BENEFITS OF MOLECULAR DIAGNOSTICS

7 BIOMARKERS INDICATION MARKET
7.1 INTRODUCTION
7.2 ONCOLOGY BIOMARKERS MARKET
7.2.1 ONCOLOGY BIOMARKERS DISCOVERY MARKET
7.2.1.1 Genomics
7.2.1.2 Proteomics
7.2.1.3 Metabolomics
7.2.1.4 Transcriptomics
7.2.1.5 Other Omics
7.2.1.6 Imaging
7.2.2 DRUG DISCOVERY & DEVELOPMENT
7.2.3 CANCER TYPES
7.2.3.1 Ovarian Cancer
7.2.3.2 Breast Cancer
7.2.3.3 Bladder Cancer
7.2.3.4 Cervical Cancer
7.2.3.5 Prostate Cancer
7.2.3.6 Lung Cancer
7.2.3.7 Colorectal Cancer
7.3 CARDIOLOGY BIOMARKERS MARKET
7.3.1 CARDIOLOGY BIOMARKERS DISCOVERY MARKET
7.3.1.1 Genomics
7.3.1.2 Proteomics
7.3.1.3 Metabolomics
7.3.1.4 Transcriptomics
7.3.1.5 Imaging
7.3.1.6 Bioinformatics
7.3.2 DRUG DISCOVERY & DEVELOPMENT
7.3.3 CARDIAC MARKERS, BY DISEASE TYPES
7.3.3.1 Acute Coronary Syndrome
7.3.3.2 Coronary artery disease
7.3.3.3 Stroke
7.3.4 CARDIOLOGY BIOMARKERS USED IN THE MARKET
7.4 NEUROLOGY BIOMARKERS MARKET
7.4.1 NEUROLOGY BIOMARKERS DISCOVERY MARKET
7.4.1.1 Omics technologies
7.4.1.2 Imaging Technologies
7.4.2 DRUG DISCOVERY & DEVELOPMENT
7.4.3 DISEASE TYPES
7.4.3.1 Alzheimer’s disease
7.4.3.2 Parkinson’s disease
7.4.3.3 Multiple sclerosis
7.4.3.4 Schizophrenia
7.4.3.5 Amyotrophic Lateral Sclerosis
7.4.3.6 Epilepsy
7.5 OTHER INDICATIONS BIOMARKERS MARKET
7.5.1 OTHER INDICATION BIOMARKERS DISCOVERY MARKET
7.5.1.1 Omics technologies
7.5.1.2 Imaging technologies
7.5.2 DRUG DISCOVERY & DEVELOPMENT
7.6 DISEASE TYPES
7.6.1 HIV
7.6.1.1 Immunological & Virological Markers in HIV Infection
7.7 RENAL FAILURE
7.8 ARTHRITIS
7.9 TUBERCULOSIS
7.10 DIABETES

8 GEOGRAPHICAL ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.3 EUROPE
8.4 ASIA
8.5 ROW

9 COMPETITIVE LANDSCAPE
9.1 KEY STRATEGIES
9.2 MERGERS & ACQUISITIONS
9.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
9.4 NEW PRODUCTS LAUNCH
9.5 OTHER DEVELOPMENTS

10 COMPANY PROFILES
10.1 ABBOTT LABORATORIES
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCTS & SERVICES
10.1.4 STRATEGY
10.1.5 DEVELOPMENTS
10.2 ABCODIA LTD
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCTS & SERVICES
10.2.4 STRATEGY
10.2.5 DEVELOPMENTS
10.3 AFFYMETRIX INC
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCTS & SERVICES
10.3.4 STRATEGY
10.3.5 DEVELOPMENTS
10.4 AGILENT TECHNOLOGIES INC
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCTS & SERVICES
10.4.4 STRATEGY
10.4.5 DEVELOPMENTS
10.5 AMGEN INC
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCTS & SERVICES
10.5.4 STRATEGY
10.5.5 DEVELOPMENT
10.6 ASTRAZENECA PLC
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCTS & SERVICES
10.6.4 STRATEGY
10.6.5 DEVELOPMENTS
10.7 AUGUREX LIFE SCIENCES CORP
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCTS & SERVICES
10.7.4 STRATEGY
10.7.5 DEVELOPMENTS
10.8 AUSHON BIOSYSTEMS INC
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCTS & SERVICES
10.8.4 STRATEGY
10.8.5 DEVELOPMENTS
10.9 BAYER AG
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCTS & SERVICES
10.9.4 STRATEGY
10.9.5 DEVELOPMENTS
10.1 BECKMAN COULTER INC
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCTS & SERVICES
10.10.4 STRATEGY
10.10.5 DEVELOPMENTS
10.11 BGI
10.11.1 OVERVIEW
10.11.2 FINANCIALS
10.11.3 PRODUCTS & SERVICES
10.11.4 STRATEGY
10.11.5 DEVELOPMENTS
10.12 BIOCRATES LIFE SCIENCES AG
10.12.1 OVERVIEW
10.12.2 FINANCIALS
10.12.3 PRODUCTS & SERVICES
10.12.4 STRATEGY
10.12.5 DEVELOPMENTS
10.13 BIOMARKERS STRATEGIES
10.13.1 OVERVIEW
10.13.2 FINANCIALS
10.13.3 PRODUCTS & SERVICES
10.13.4 STRATEGY
10.13.5 DEVELOPMENTS
10.14 BIOSYSTEMS INTERNATIONAL
10.14.1 OVERVIEW
10.14.2 FINANCIALS
10.14.3 PRODUCTS & SERVICES
10.14.4 STRATEGY
10.14.5 DEVELOPMENTS
10.15 BRISTOL-MYERS SQUIBB
10.15.1 OVERVIEW
10.15.2 FINANCIALS
10.15.3 PRODUCTS & SERVICES
10.15.4 STRATEGY
10.15.5 DEVELOPMENTS
10.16 CRESCENDO BIOSCIENCE
10.16.1 OVERVIEW
10.16.2 FINANCIALS
10.16.3 PRODUCTS & SERVICES
10.16.4 STRATEGY
10.16.5 DEVELOPMENTS
10.17 EISAI CO. LTD.
10.17.1 OVERVIEW
10.17.2 FINANCIALS
10.17.3 PRODUCTS & SERVICES
10.17.4 STRATEGY
10.17.5 DEVELOPMENTS
10.18 EPIONTIS GMBH
10.18.1 OVERVIEW
10.18.2 FINANCIALS
10.18.3 PRODUCTS & SERVICES
10.18.4 DEVELOPMENTS
10.19 EPISTEM HOLDINGS PLC
10.19.1 OVERVIEW
10.19.2 FINANCIALS
10.19.3 PRODUCTS & SERVICES
10.19.4 STRATEGY
10.19.5 DEVELOPMENTS
10.20 EUROGENTEC S.A.
10.20.1 OVERVIEW
10.20.2 FINANCIALS
10.20.3 PRODUCTS & SERVICES
10.20.4 STRATEGY
10.20.5 DEVELOPMENTS
10.21 EVOTEC AG
10.21.1 OVERVIEW
10.21.2 FINANCIALS
10.21.3 PRODUCTS & SERVICES
10.21.4 STRATEGY
10.21.5 DEVELOPMENTS
10.22 GLAXOSMITHKLINE PLC
10.22.1 OVERVIEW
10.22.2 FINANCIALS
10.22.3 PRODUCTS & SERVICES
10.22.4 STRATEGY
10.22.5 DEVELOPMENTS
10.23 IPSEN
10.23.1 OVERVIEW
10.23.2 FINANCIALS
10.23.3 PRODUCTS & SERVICES
10.23.4 STRATEGY
10.23.5 DEVELOPMENTS
10.24 JOHNSON & JOHNSON
10.24.1 OVERVIEW
10.24.2 FINANCIALS
10.24.3 PRODUCTS & SERVICES
10.24.4 STRATEGY
10.24.5 DEVELOPMENTS
10.25 MERCK & CO.
10.25.1 OVERVIEW
10.25.2 FINANCIALS
10.25.3 PRODUCTS & SERVICES
10.25.4 STRATEGY
10.25.5 DEVELOPMENTS
10.26 MICROMEDIC TECHNOLOGIES LTD
10.26.1 OVERVIEW
10.26.2 PRODUCTS & SERVICES
10.26.3 STRATEGY
10.26.4 DEVELOPMENTS
10.27 MYRIAD GENETICS INC
10.27.1 OVERVIEW
10.27.2 FINANCIALS
10.27.3 PRODUCTS & SERVICES
10.27.4 STRATEGY
10.27.5 DEVELOPMENTS
10.28 NEXTGEN SCIENCES INC
10.28.1 OVERVIEW
10.28.2 FINANCIALS
10.28.3 PRODUCTS & SERVICES
10.28.4 STRATEGY
10.28.5 DEVELOPMENTS
10.29 NOVARTIS INTERNATIONAL AG
10.29.1 OVERVIEW
10.29.2 FINANCIALS
10.29.3 PRODUCTS & SERVICES
10.29.4 STRATEGY
10.29.5 DEVELOPMENTS
10.30 OCIMUM BIOSOLUTIONS LTD
10.30.1 OVERVIEW
10.30.2 FINANCIALS
10.30.3 PRODUCTS & SERVICES
10.30.4 STRATEGY
10.30.5 DEVELOPMENTS
10.31 PFIZER INC
10.31.1 OVERVIEW
10.31.2 FINANCIALS
10.31.3 PRODUCTS & SERVICES
10.31.4 STRATEGY
10.31.5 DEVELOPMENTS
10.32 PRONOTA NV
10.32.1 OVERVIEW
10.32.2 FINANCIALS
10.32.3 PRODUCTS & SERVICES
10.32.4 STRATEGY
10.32.5 DEVELOPMENTS
10.33 QUINTILES TRANSNATIONAL CORPORATION
10.33.1 OVERVIEW
10.33.2 FINANCIALS
10.33.3 PRODUCTS & SERVICES
10.33.4 STRATEGY
10.33.5 DEVELOPMENTS
10.34 QIAGEN NV
10.34.1 OVERVIEW
10.34.2 FINANCIALS
10.34.3 PRODUCTS & SERVICES
10.34.4 STRATEGY
10.34.5 DEVELOPMENTS
10.35 ROCHE DIAGNOSTICS LIMITED
10.35.1 OVERVIEW
10.35.2 FINANCIALS
10.35.3 PRODUCTS & SERVICES
10.35.4 STRATEGY
10.35.5 DEVELOPMENT
10.36 SANOFI-AVENTIS
10.36.1 OVERVIEW
10.36.2 FINANCIALS
10.36.3 PRODUCTS & SERVICES
10.36.4 STRATEGY
10.36.5 DEVELOPMENT
10.37 SIEMENS HEALTHCARE
10.37.1 OVERVIEW
10.37.2 FINANCIALS
10.37.3 PRODUCTS & SERVICES
10.37.4 STRATEGY
10.37.5 DEVELOPMENTS
10.38 TRANS-HIT BIOMARKERS INC
10.38.1 OVERVIEW
10.38.2 FINANCIALS
10.38.3 PRODUCTS & SERVICES
10.38.4 STRATEGY
10.38.5 DEVELOPMENTS
10.39 PACIFIC BIOMARKERS INC
10.39.1 OVERVIEW
10.39.2 FINANCIALS
10.39.3 PRODUCTS & SERVICES
10.39.4 STRATEGY
10.39.5 DEVELOPMENTS
10.40 CAPRION PROTEOMICS INC.
10.40.1 OVERVIEW
10.40.2 FINANCIALS
10.40.3 PRODUCTS & SERVICES
10.40.4 STRATEGY
10.40.5 DEVELOPMENTS
10.41 PROTEOME SCIENCES PLC
10.41.1 OVERVIEW
10.41.2 FINANCIALS
10.41.3 PRODUCTS & SERVICES
10.41.4 STRATEGY
10.41.5 DEVELOPMENTS
10.42 VERMILLION INC
10.42.1 OVERVIEW
10.42.2 FINANCIALS
10.42.3 PRODUCTS & SERVICES
10.42.4 STRATEGY
10.42.5 DEVELOPMENTS


【レポート販売概要】

■ タイトル:世界のバイオマーカー市場
■ 英文:Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013-2018)
■ 発行日:2013年9月
■ 調査会社:MarketsandMarkets
■ 商品コード:BT 2120
■ 調査対象地域:グローバル
  • 液体クロマトグラフィー用試薬の世界市場:カラムクロマトグラフィー、平面クロマトグラフィー
    The global liquid chromatography reagents market is estimated to grow at a CAGR of 11.1% from 2014 to 2019. North America accounted for the largest share of this market, to grow at a CAGR of 9.3%. The global liquid chromatography reagents market holds high potential for growth in future, due to increasing strategic expansions of companies and advances in the pharmaceutical and biotechnology indust …
  • Qatar Electricity & Water Company Q.S.C.:発電所及び企業SWTO分析2015
    Qatar Electricity & Water Company Q.S.C. - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (ass …
  • アンテナ/送受波器/レドームの世界市場
    The antenna, transducer, and radome market is projected to reach USD 12.48 Billion by 2020, at a CAGR of 9.53% from 2015 to 2020. Antennas are predominantly used in communications system for data transfer from one location to another, whereas radomes are devices which protect microwave antennas from harsh weather conditions and provide a proper enclosure to the equipment. The antenna, transducer, …
  • 世界の高度分析(Advanced Analytics)市場動向(2012-2016)
    TechNavio's analysts forecast the Global Advanced Analytics market to grow at a CAGR of 13.62 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growth of predictive analytics. The Global Advanced Analytics market has also been witnessing the emergence of advanced analytics in social gaming. However, the lack of expertise could pose a challenge to t …
  • PLCスプリッタの世界市場予測及び分析
    This is the ElectroniCast analysis and forecast of global market consumption of planar lightwave circuit (PLC) splitters used in optical communication applications. For the purposes of this study, ElectroniCast specifically addresses the PLC splitter, using waveguide circuits and aligned fiber optic pigtails, integrated inside a package. The 2014-2019 quantitative market forecast data presented in …
  • ニュートリゲノミクスの世界市場:用途別(肥満、心血管疾患、がん研究)、地域別、セグメント予測
    The global nutrigenomics market size is expected to reach USD 850.86 million by 2025 registering a CAGR of 16.48%, according to a new report by Grand View Research, Inc. This growth can be attributed to the rising cases of obesity and Cardiovascular Diseases (CVDs), particularly in developed regions. Nutrigenomics can play a vital role in the prevention of obesity by offering personalized, gene-ba …
  • ニュートリコスメティクスの世界市場予測・分析2020-2024
    Global Nutricosmetics Market: About this market Technavio’s nutricosmetics market analysis considers sales from both offline and online distribution channels. Our study also finds the sales of nutricosmetics in APAC, Europe, MEA, North America, and South America. In 2019, the offline segment had a significant market share, and this trend is expected to continue over the forecast period. Factors su …
  • 世界のコーティング添加剤市場
    Coating additives are specially engineered and developed materials, witnessing growth in market demand. This growth is driven by the end-user segments where they are being used extensively owing to their ability to improve the performance of the coating chemically, and make it visually appealing. Coating additives contribute towards the improvement of factors that affect the performance of coating …
  • ポリデキストロースの世界市場分析:製品別(粉末、液体)、用途別(栄養食品、製パン・製菓、飲料、培養乳製品)、地域別(北アメリカ、ヨーロッパ、アジア太平洋、中南米、MEA)、セグメント予測
    The global polydextrose market is expected to reach USD 386 million by 2025, according to a new report by Grand View Research, Inc. Rising demand to enhance the non-dietary fiber content in food is expected to boost the market growth. Increasing utilization of polydextrose as sugar supplement in food and as a prebiotic dietary fiber is projected to propel the market demand. Major raw materials use …
  • 非鉄金属鋳物の世界市場:アルミニウム鋳物、銅鋳物、亜鉛鋳物、マグネシウム鋳物
    About Non-ferrous Casting Metal casting is a manufacturing process in which metal (molten or liquid) is poured into a mold made of sand or ceramic plaster. The mold contains a hollow cavity of the desired shape, to form geometrically complex parts. The most common non-ferrous metals used for casting are aluminum, magnesium, zinc, and copper-based alloys. Metal casting finds application in vehicles …
  • Oncology Therapeutics Market in India to 2018 – Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players
    Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players Summary GBI Research, the leading business intelligence provider, has released its latest research, "Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Am …
  • ZigBeeリモコンの世界市場2017-2021
    About ZigBee Remotes ZigBee is a wireless and open, global standard with added benefits such as low-cost, low-power wireless M2M networks. The ZigBee standard is the only wireless technology that enables device-to-device communication in any market and functions on IEEE 802.15.4 physical radio specification in unsanctioned bands that include 2.4 GHz, 900 MHz, and 868 MHz. Technavio’s analysts fore …
  • 世界のヒ素市場:市場規模、動向、メーカー動向
    Scope The report presents a thorough study of arsenic, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing arsenic production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: arsenic product …
  • 乾癬性関節炎治療薬の世界市場2015-2019
    Psoriatic arthritis is a chronic inflammatory disease that affects the distal joints in the body and may also affect the back and sacroiliac joints of the pelvis. The global market for psoriatic arthritis is expected to witness moderate growth during the forecast period and factors like the increase in penetration of biologic therapies are expected to augment the prospects for growth in this marke …
  • クラスルーム・コラボレーション管理システムの世界市場
    Technavios market research analysts predict the global classroom collaboration management systems market to grow at a CAGR of close to 19% during the forecast period. Increased adoption of synchronous e-learning in educational institutions has significantly influenced the growth of this market. The software is likely to penetrate the education sector as many educational institutions are deploying …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。